The aim of the authorisation process is to:
​

• Ensure that the risks related to substances of very high concern (SVHCs) are properly controlled throughout their life cycle
• Promote the progressive replacement of SVHCs by suitable alternatives (less dangerous substances, new technologies and processes), where technically and economically feasible alternatives are available.

The three-phase authorisation process:​
​

• Phase I - Substances of very high concern (SVHC)
  • Registry of SVHC intentions until outcome
  • Preparing the SVHC dossier
  • Consultation
  • Adding substances to the Candidate List
• Phase II - Recommendation for inclusion in the Authorisation List
  • Prioritisation
  • Draft recommendation
  • Consultation
  • MSC opinion
  • Recommendation and inclusion in the Authorisation List
• Phase III - Application for authorisation
  • Application for authorisation
  • Consultation
  • RAC and SEAC opinions
  • Commission decision
  • Implementation
  • Review report, if the company needs to continue using the substance after the end of the review period

​